Paper - WANFANG MED ONLINE

You Position: Home > Paper

Lung computed tomography screening radiology and clinical management of ground-glass nodule

( views:408, downloads:2061 )

Author:: No author available

Journal Title:: Chinese Journal of Health Management

Issue:: 2

DOI:: 10.3760/cma.j.issn.1674-0815.2019.02.017

Key Word:: 肺癌;计算机断层扫描;筛查诊断;干预控制

Abstract：低剂量CT广泛运用于肺癌筛查,能明显增加肺结节及早期肺癌的检出率,降低肺癌的死亡率,但由于肺结节中恶性肿瘤所占比例低,精密检查也带来了辐射暴露、过度治疗、医疗资源浪费等问题.肺结节中磨玻璃结节(GGN)的恶性率远高于实性结节且多呈惰性生长,是诊断、评估和干预的重点及难点.本综述主要通过分析GGN的影像学表现和病理学基础,回顾肺结节诊治中国专家共识(2018年版)、弗莱施纳学会、肺部影像报告和数据系统、美国国立综合癌症网络和英国胸科协会等指南总结的GGN风险评估和临床处理策略,根据CT特征和结节动态变化给出随访建议及临床介入干预的依据,使胸部低剂量CT为基础的肺癌筛查及检后管理更加系统、安全、可靠.

Reference

[1]中华医学会呼吸病学分会肺癌学组,中国肺癌防治联盟专家组.肺结节诊治中国专家共识（2018年版）[J].2018,(10).
[2]袁立功,毛友生.胸段食管癌喉返神经旁淋巴结转移对食管癌颈部淋巴结清扫的指导价值[J].2019,(1).
[3]Alexander A, Bankier,Heber, MacMahon,Jin Mo, Goo,etc.Recommendations for Measuring Pulmonary Nodules at CT: A Statement from the Fleischner Society.[J].2017,(Spec ).
[4]Al-Ameri, Ali,Malhotra, Puneet,Thygesen, Helene,etc.Risk of malignancy in pulmonary nodules: A validation study of four prediction models[J].2015,89(1).
[5]de Hoop B,Gietema H,van de Vorst S,etc.Pulmonary ground-glass nodules: increase in mass as an early indicator of growth.[J].2010,255(1).
[6]C I, Henschke.Early lung cancer action project: overall design and findings from baseline screening.[J].2000,89.
[7]Kobayashi, Y.,Mitsudomi, T.,Sakao, Y.,etc.Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth[J].2015,26(1).
[8]Momen M. Wahidi,Joseph A. Govert,Ranjit K. Goudar,etc.Evidence for the Treatment of Patients With Pulmonary Nodules: When Is It Lung Cancer?: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)[J].2007,132(3).
[9]Veronesi, Giulia,Travaini, Laura L.,Maisonneuve, Patrick,etc.Positron emission tomography in the diagnostic work-up of screening-detected Lung nodules[J].2015,45(2).
[10]Rizzo, Stefania,Petrella, Francesco,Buscarino, Valentina,etc.CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer[J].2016,26(1).
[11]Baldwin, David R.,Callister, Matthew E. J..The British Thoracic Society guidelines on the investigation and management of pulmonary nodules[J].2015,70(8).
[12]Hong, Qun-Ying,Wu, Guo-Ming,Qian, Gui-Sheng,etc.Prevention and management of lung cancer in China[J].2015,121(17September 1.).
[13]S J, Swensen,M D, Silverstein,D M, Ilstrup,etc.The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules.[J].1997,157(8).
[14]Boksoon Chang,Jung Hye Hwang,Yoon-Ho Choi,etc.Natural History of Pure Ground-Glass Opacity Lung Nodules Detected by Low-Dose CT Scan[J].2013,143(1).
[15]Ho Yun, Lee,Yoon-La, Choi,Kyung Soo, Lee,etc.Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management.[J].2014,202.
[16]McWilliams,A.,Tammemagi,M.C.,Mayo,J.R.,etc.Probability of cancer in pulmonary nodules detected on first screening CT[J].2013,369(10).
[17]Douglas E, Wood,Ella A, Kazerooni,Scott L, Baum,etc.Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.[J].2018,16(4).
[18]Bray Freddie,Ferlay Jacques,Soerjomataram Isabelle,etc.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].2018,68(6).
[19]Yoshimura,M.,Okada,M.,Miyata,Y.,etc.Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: A multicenter study[J].2012,143(3).
[20]Aberle DR,Adams AM,Berg CD,etc.Reduced lung-cancer mortality with low-dose computed tomographic screening.[J].2011,365(5).
[21]Asamura,H.,Hishida,T.,Suzuki,K.,etc.Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201[J].2013,146(1).
[22]Aberle,D.R.,DeMello,S.,Berg,C.D.,etc.Results of the two incidence screenings in the National Lung Screening Trial[J].2013,369(10).
[23]Yankelevitz, David F.,Yip, Rowena,Smith, James P.,etc.CT Screening for Lung Cancer: Nonsolid Nodules in Baseline and Annual Repeat Rounds[J].2015,277(2).
[24]Tsao, Ming-Sound,Marguet, Sophie,Le Teuff, Gwenael,etc.Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection[J].2015,33(30).
[25]Rami-Porta, R.,Ball, D.,Crowley, J.,etc.The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer[J].2007,2(7).
[26]Zhang, H.,Heuvelmans, M. A.,Xie, X. Q.,etc.Changes in quantitative CT image features of ground-glass nodules in differentiating invasive pulmonary adenocarcinoma from benign and in situ lesions: histopathological comparisons[J].2018,73(5).
[27]V T, DeVita,R C, Young,G P, Canellos.Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer.[J].1975,35(1).
[28]Mahdavi, Maziyar,Rahimi, Saeed,Eghlidospoor, Mahsa..Evaluation of some spiral and sequential computed tomography protocols of adults used in three hospitals in Shiraz, Iran with American College of Radiology and European Commission guidelines.[J].2018,83.
[29]Carole A, Ridge,Alexander A, Bankier,Ronald L, Eisenberg.Mosaic attenuation.[J].2011,197(6).
[30]Sox HC.Better evidence about screening for lung cancer.[J].2011,365(5).
[31]Travis, William D.,Brambilla, Elisabeth,Burke, Allen P.,etc.Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart[J].2015,10(9).
[32]Lim,H.-J.,Ahn,S.,Lee,K.S.,etc.Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: Histopathologic comparisons and prognostic implications[J].2013,144(4).
[33]Sung-Jun Ko,Yeon Joo Lee,Jong Sun Park,etc.Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity.[J].2014,14(1).
[34]David S, Ettinger.Ten years of progress in non-small cell lung cancer.[J].2012,10(3).